United StatesÚltimas notícias

President Donald Trump says no one in the US is better prepared to lead the Federal Reserve than Kevin Warsh as he swears Warsh in at the White House as the 17th chair of the Fed.

Inflation is exposing a major divide in the US economy according to Citi Retailing and Hardlines Analyst Steven Zaccone, He joins Bloomberg Open Interest to explain why wealthy consumers keep spending while lower-income shoppers struggle with rising gas and living costs. From Walmart and BJ's to Williams-Sonoma and AutoZone, we look at the retail winners and losers in today's "K-shaped" economy.

Bond traders are fully pricing in an interest-rate hike by the Federal Reserve this year, a sign of conviction in the market that incoming Chair Kevin Warsh will need to move quickly to combat inflation. Traders boosted their bets for higher rates on Friday after Fed Governor Christopher Waller said he supports making clear the central bank's next interest-rate move is just as likely to be an increase as a cut. Interest-rate swaps imply that the market sees the Fed's benchmark rate at least 25 basis points higher by the end of 2026. It's a complete turnaround from earlier this year, when President Trump's selection of Warsh to lead the Fed inspired Wall Street to bet on several rate reductions in 2026. Traders quickly re-calibrated those wagers after the US and Israel attacked Iran in late February. For more on the inflation outlook, we speak with Kathy Bostjancic, Senior Vice President & Chief Economist at Nationwide.

Is it the end of fintech and investing apps as we know it? Atomic Invest CEO David Dindi joins Bloomberg Open Interest to talk about the future of finance and why it belongs to AI companions, not apps. He says investing apps could disappear within a decade as AI assistants manage portfolios for consumers.

Axon President Josh Eisner joins Bloomberg Open Interest to explain why Wall Street is misunderstanding the company's AI strategy. From  drones to enterprise security and public safety software, Eisner says Axon is evolving far beyond Tasers and body cameras, and betting aggressively on AI to drive its next wave of growth.

Dr. Doug Lucas, Orthopedic Surgeon; Clinical Lead, Bone Health & Longevity at LifeMD says osteoporosis affects millions of women, yet bone health still feels under-discussed. He adds that osteoporosis can be easily prevented with things like healthy protein forward diet, exercise, and supplements, much earlier in life. Dr. Lucas says those are the keys to bone health and longevity.

On this episode of Stock Movers with Alexis Christoforous: - Estee Lauder (EL) share are climbing following collapse of a proposed combination with Puig Brands that would have created one of the world's largest fragrance and skincare companies. - IMAX Corp. (IMAX) shares jumped after the Wall Street Journal reported the large-screen theater company is exploring a sale and has approached entertainment companies as potential buyers. - Ross Stores (ROST) shares are up after the off-price retailer boosted its comparable sales forecast for the full year. The firm also posted better-than-expected sales for the first quarter.

Federal Reserve Governor Christopher Waller now says he can't rule out voting to raise interest rates if inflation doesn't start to slow soon, saying "inflation is not headed in the right direction." Waller made the comments during a speech in Germany. Bloomberg's Michael McKee reports.

Stellantis is making a dramatic U-turn, bringing back affordable Chrysler SUVs, reviving Dodge muscle cars, and expanding Ram with new SUVs and pickups. As inflation crushes car buyers, the automaker is abandoning its luxury-first strategy to win back mainstream America. Bloomberg's Auto Reporter Gabrielle Coppola joined Bloomberg Open Interest to talk about the pivot and what's ahead for the carmaker.

The US State Department's point man for APEC says the group of 21 countries is an important customer for American goods and services - including energy. Bloomberg's Chief North Asia Correspondent Stephen Engle spoke with Casey Mace, the US senior official to APEC, on the sidelines of the APEC trade ministers meeting in China.

The U.S. Food and Drug Administration (FDA) has approved Datroway (datopotamab deruxtecan-dlnk) for the treatment of adult patients with unresectable or metastatic triple-negative breast cancer (TNBC) who are not candidates for PD-1/PD-L1 inhibitor therapy.

Agios Pharmaceuticals (NASDAQ:AGIO) announced that the European Commission has granted marketing authorization for Pyrukynd (mitapivat) to treat anemia in adult patients with alpha- or beta-thalassemia.